Romulus K. Brazzell

Insider Reports History

Location
Durham, NC
Signature
/s/ Mary Reumuth, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Romulus K. Brazzell:

Form 4 holding Head of Research and Development and Chief Medical Officer

KALA BIO, Inc.

Security class
Common Stock
Shares / value
35,952
Estimated value
$73,701
Report date
22 Oct 2025
Price
$2.05
Ownership
Direct
Form 4 holding Head of Research and Development and Chief Medical Officer

KALA BIO, Inc.

Security class
Stock Option (right to buy)
Shares / value
45,200
Estimated value
Report date
06 Jan 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Romulus K. Brazzell

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .